This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Beijing Percans Oncology Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Dagang Guo
Introduction
Dagang Guo is a prominent inventor based in Beijing, China. He has made significant contributions to the field of oncology through his innovative research and development of cytokine fusion proteins. His work aims to enhance cancer treatment options and improve patient outcomes.
Latest Patents
Dagang Guo holds a patent for cytokine fusion proteins. This patent includes cytokine fusion proteins that comprise a first cytokine fused to a second cytokine. For example, interleukin-2 (IL-2) or interferon-β (IFN-β) is fused to the N-terminus of tumor necrosis factor-α (TNF-α). These proteins are designed for treating cancers, either as standalone agents or in combination with autologous tumor vaccines and/or immune checkpoint modulatory agents. He has 1 patent to his name.
Career Highlights
Dagang Guo is associated with Beijing Percans Oncology Co., Ltd., where he continues to advance his research in cancer therapies. His work is characterized by a commitment to developing innovative solutions that address critical challenges in oncology.
Collaborations
Dagang Guo collaborates with Yiyou Chen, contributing to the advancement of their shared goals in cancer research and treatment.
Conclusion
Dagang Guo's innovative work in cytokine fusion proteins represents a significant advancement in cancer treatment. His contributions are paving the way for new therapeutic options that could greatly benefit patients facing cancer.